Why GLOBUS MEDICAL INC - A (NYSE:GMED) qualifies as a high growth stock.

Our stock screener has flagged GLOBUS MEDICAL INC - A (NYSE:GMED) as a potential breakout candidate. This occurs when the stock shows signs of consolidation after a notable upward trend. While we can't predict the actual breakout, it's worth monitoring NYSE:GMED for potential movement.

What is the technical picture of NYSE:GMED telling us.

ChartMill assigns a proprietary Technical Rating to each stock. The score is computed daily by evaluating various technical indicators and properties. The score ranges from 0 to 10.

Overall GMED gets a technical rating of 10 out of 10. Both in the recent history as in the last year, GMED has proven to be a steady performer, scoring decent points in every aspect analyzed.

• Both the short term and long term trends are positive. This is a very positive sign.
• When comparing the yearly performance of all stocks, we notice that GMED is one of the better performing stocks in the market, outperforming 90% of all stocks. On top of that, GMED also shows a nice and consistent pattern of rising prices.
• GMED is part of the Health Care Equipment & Supplies industry. There are 187 other stocks in this industry. GMED outperforms 86% of them.
• GMED is currently trading in the upper part of its 52 week range. The S&P500 Index is also trading in the upper part of its 52 week range, so GMED is performing more or less in line with the market.

For an up to date full technical analysis you can check the technical report of GMED

Looking at the Setup

Alongside the Technical Rating, ChartMill assigns a Setup Rating to evaluate the consolidation level of a stock. This rating, ranging from 0 to 10, is updated daily and considers various short-term technical indicators. The current setup rating for NYSE:GMED is 9:

GMED has an excellent technical rating and also presents a decent setup pattern. Prices have been consolidating lately. There is a resistance zone just above the current price starting at 85.61. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 82.42, a Stop Loss order could be placed below this zone. We notice that large players showed an interest for GMED in the last couple of days, which is a good sign.

Why NYSE:GMED may be interesting for high growth investors.

• The EPS of GLOBUS MEDICAL INC - A has exhibited growth from one quarter to another (Q2Q), with a 45.61% increase. This underscores the company's ability to generate higher earnings and improve its financial standing.
• GLOBUS MEDICAL INC - A has achieved significant quarter-to-quarter (Q2Q) revenue growth of 63.1%, signaling its ability to capture market opportunities and drive top-line expansion. This growth underscores the company's effective execution and its potential for continued success.
• With notable 1-year revenue growth of 102.0%, GLOBUS MEDICAL INC - A exemplifies its ability to generate increased sales and revenue streams. This growth signifies the company's strong business performance and its potential for future growth.
• The quarterly earnings of GLOBUS MEDICAL INC - A have shown a 45.61% increase compared to the previous quarter, as revealed in the recent financial report. This growth signifies positive momentum in the company's financials, pointing towards a promising upward trend
• GLOBUS MEDICAL INC - A shows accelerating EPS growth: when comparing the current Q2Q growth of 45.61% to the previous year Q2Q growth of 14.0%, we see the growth rate improving.
• The free cash flow (FCF) of GLOBUS MEDICAL INC - A has seen steady growth over the past year, indicating enhanced cash flow generation and financial health. This trend underscores the company's effective capital management and its ability to generate sustainable cash flows.
• GLOBUS MEDICAL INC - A exhibits a favorable Debt-to-Equity ratio at 0.0. This highlights the company's ability to limit excessive debt levels and maintain a strong equity base, demonstrating its financial stability and risk management practices.
• With a track record of beating EPS estimates 3 times in the last 4 quarters, GLOBUS MEDICAL INC - A showcases its consistent ability to deliver earnings surprises. This reflects the company's strong execution and its competitive position in the market.
• GLOBUS MEDICAL INC - A has maintained a healthy Relative Strength (RS) over the analyzed period, with a current 90.28 rating. This demonstrates the stock's ability to outperform its peers and indicates its competitive positioning. GLOBUS MEDICAL INC - A is well-positioned for potential price growth opportunities.

More high growth momentum breakout stocks can be found in our High Growth Momentum Breakout screen.

Keep in mind

This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.